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Duchenne muscular dystrophy is a fatal X-linked disease charac-
terized by the absence of dystrophin. Approximately 20% of boys
will die of dilated cardiomyopathy that is associated with cyto-
skeletal protein disarray, contractile dysfunction, and reduced
energy production. However, the mechanisms for altered energy
metabolism are not yet fully clarified. Calcium influx through the
L-type Ca2+ channel is critical for maintaining cardiac excitation
and contraction. The L-type Ca2+ channel also regulates mitochon-
drial function and metabolic activity via transmission of movement
of the auxiliary beta subunit through intermediate filament pro-
teins. Here, we find that activation of the L-type Ca2+ channel is
unable to induce increases in mitochondrial membrane potential
and metabolic activity in intact cardiac myocytes from the murine
model of Duchenne muscular dystrophy (mdx) despite robust
increases recorded in wt myocytes. Treatment of mdx mice with
morpholino oligomers to induce exon skipping of dystrophin exon
23 (that results in functional dystrophin accumulation) or applica-
tion of a peptide that resulted in block of voltage-dependent an-
ion channel (VDAC) “rescued” mitochondrial membrane potential
and metabolic activity in mdx myocytes. The mitochondrial VDAC
coimmunoprecipitated with the L-type Ca2+ channel. We conclude
that the absence of dystrophin in the mdx ventricular myocyte
leads to impaired functional communication between the L-type
Ca2+ channel and mitochondrial VDAC. This appears to contribute
to metabolic inhibition. These findings provide new mechanistic and
functional insight into cardiomyopathy associated with Duchenne
muscular dystrophy.
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Duchenne muscular dystrophy affects 1:3,500 males, and inaddition to skeletal muscle damage and atrophy, boys also
develop a dilated cardiomyopathy due to the absence of expression
of dystrophin. This pathology involves myocyte remodelling, disor-
ganization of cytoskeletal proteins, and contractile dysfunction
(1, 2). Early metabolic and signaling alterations have been reported
in 10- to 12-wk-old murine model of Duchenne muscular dystrophy
(mdx) hearts before the development of overt contractile dysfunc-
tion (2). However, the mechanisms by which absence of dystrophin
leads to mitochondrial dysfunction and compromised cardiac
function in mdx hearts are not fully clarified yet.
Cytoskeletal proteins stabilize cell structure. In mature mus-
cle, intermediate filaments form a 3D scaffold that extend from
the Z disks to the plasma membrane and traverse cellular organelles
such as t-tubules, sarcoplasmic reticulum, and mitochondria (3).
Intermediate filaments and microtubules interact directly with mi-
tochondria by binding to outer mitochondrial membrane proteins.
In addition to a physical association, cytoskeletal proteins also
regulate the function of proteins in the plasma membrane and
within the cell (4). The L-type Ca2+ channel (ICa-L) or dihydrop-
yridine receptor (DHPR) is anchored to F-actin networks by
subsarcolemmal stabilizing proteins that also tightly regulate the
function of the channel (5–7). Disruption of actin filaments
significantly alters ICa-L current (5, 7, 8).
Calcium influx through ICa-L is a requirement for contraction.
ICa-L can also regulate mitochondrial function. Activation of ICa-L
with application of the DHPR agonist BayK(-) or voltage clamp of
the plasma membrane can influence mitochondrial superoxide
production, NADH production, and metabolic activity in a calcium-
dependent manner (9, 10). Activation of ICa-L can also increase
mitochondrial membrane potential (Ψm) in a calcium-independent
manner (9). The response is reversible upon inactivation of ICa-L.
The response also depends on actin filaments because depolymeri-
zation of actin prevents the increase in Ψm (9). Similarly preventing
movement of the beta auxiliary subunit of ICa-L with application of
a peptide derived against the alpha-interacting domain of the
channel attenuates the increase in Ψm (9). Therefore, we have
proposed that ICa-L influences metabolic activity through trans-
mission of movement of the channel via cytoskeletal proteins.
Here, we sought to identify whether cytoskeletal disruption due to
the absence of dystrophin leads to mitochondrial dysfunction and
compromised cardiac function in mdx hearts. Specifically, we
investigated whether the absence of dystrophin in ventricular
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myocytes frommdxmice results in impaired communication between
ICa-L and mitochondria and, subsequently, metabolic inhibition.
Results
ICa-L Measured in mdx Myocytes Exhibit Altered Inactivation Kinetics.
We measured ICa-L currents in myocytes isolated from hearts of
mdx mice and compared them with currents recorded from wt
myocytes. Consistent with previous reports (11, 12) we find ICa-L
current density in myocytes from 8-wk-old wt mice is not dif-
ferent from current density recorded in myocytes from 8-wk-old
mdxmice (6.2 ± 0.8 pA/pF, n = 10 vs. 7.9 ± 1.6 pA/pF, n = 9; P =
not significant). In addition, there was no difference in cell size
betweenmdx and wtmyocytes (12). Through immunoblotting, we
confirm that channel expression is not altered in mdx myocytes
(Fig. S1). However, in mdx myocytes, the inactivation of the
current was significantly slower (τ = 26.15 ± 1.75 vs. 21.06 ± 1.29
ms; Fig. 1 A and B). Consistent with a delayed inactivation rate,
we have demonstrated that the inactivation integral of current
and total integral of current are significantly greater in myocytes
from mdx hearts compared with myocytes from wt hearts (12).
Additionally, the activation integral of current in mdx and wt
myocytes does not differ (12). The delayed inactivation of the
current persists in the mdx myocyte when barium is used as
a carrier (13). We cannot definitively state that alterations in
intracellular calcium are not responsible for the response; how-
ever, these findings suggest that the delay in inactivation may
occur as a result of alterations in cytoskeletal structure. Consis-
tent with this argument and with previous reports, we find that
immobilizing the beta subunit of ICa-L by exposing wt myocytes to
a peptide derived against the alpha-interacting domain (AID) of
Fig. 1. Absence of dystrophin alters ICa-L current and Ψm in mdx myocytes. (A) ICa-L current traces recorded from a myocyte from a mdx heart and a myocyte
from awt heart as indicated. (A, Inset) ICa-L current traces from awtmyocyte (250 pF) exposed to a peptide derived against the alpha-interacting domain of ICa-L
(AID-TAT, 1 μM) or awtmyocyte (220 pF) exposed to a scrambled control peptide [AID(S)-TAT, 1 μM] as indicated. Microelectrodes contained the following: 115
mM CsCl, 10 mM Hepes, 10 mM EGTA, 20 mM tetraethylammonium chloride, 5 mM MgATP, 0.1 mM Tris-GTP, 10 mM phosphocreatine, and 1 mM CaCl2 (pH
adjusted to 7.05 at 37 °C with CsOH). Currents were measured in extracellular modified Tyrode’s solution containing the following: 140 mM NaCl, 5.4 mM CsCl,
2.5 mM CaCl2, 0.5 mMMgCl2, 5.5 mM Hepes, and 11 mM glucose (pH adjusted to 7.4 with NaOH). (B) Mean ± SEM of rate of inactivation (tau) formdxmyocytes
and wtmyocytes. (C–F) Direct activation of ICa-L results in an increase in Ψm in wt but notmdxmyocytes. Representative ratiometric JC-1 fluorescence recorded
fromwtmyocytes (C), andmdxmyocytes (D), before and after exposure to 10 μMBayK(-) or 10 μMBayK(+). Vertical arrow indicates when drug was added. Four
millimolar KCN was added to collapse Ψm as indicated. Mean ± SEM of increases in JC-1 fluorescence for all wt (E) and mdx (F) myocytes exposed to treatments
as indicated. Nisol, 10 μM nisoldipine; Oligo, 20 μM oligomycin. Oligo alone induced a robust increase in JC-1 signal in mdx myocytes.
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ICa-L slows inactivation of the current (AID-TAT; Fig. 1 A, Inset)
(6, 9, 10). Because the auxiliary beta subunit regulates in-
activation of ICa-L current (14, 15), we propose that the alter-
ations in ICa-L inactivation in the mdx myocyte result from
disruption of the cytoskeleton due to the absence of dystrophin.
Direct Activation of ICa-L Increases Ψm in wt but Not mdx Myocytes.
We have demonstrated that activation of ICa-L with application
of DHPR agonist BayK(-) or voltage clamp of the plasma mem-
brane results in an increase inΨm in guinea-pig ventricular myocytes
(9). BayK(-) increases ICa-L in the mdx myocyte (12). We examined
whether the absence of dystrophin altered the increase in Ψm after
application of Bay K(-) in myocytes from mdx mice. We performed
experiments in quiescent ventricular myocytes with consistent ATP
utilization because this approach allowed us to more readily explore
the effects of ICa-L activation on mitochondrial function. Exposure
of wild-type (wt) myocytes to BayK(-) increased Ψm measured
as changes in JC-1 signal by 7.61 ± 1.04% compared with wt
myocytes exposed to inactive enatiomer BayK(+) (Fig. 1 C and
E). The response could be attenuated with application of ICa-L
antagonist nisoldipine. However, in mdx myocytes, BayK(-)
could not elicit an increase in JC-1 signal (Fig. 1 D and F).
Myocytes from mdx hearts exhibited functional electron trans-
port because the ATP synthase blocker oligomycin induced a sig-
nificant increase in JC-1 signal (Fig. 1 D and F). To further
confirm that the signal was measuring changes in Ψm, we induced
a collapse of Ψm with application of potassium cyanide (KCN)
(Fig. 1 C and D).
Alterations in Ψm After Activation of ICa-L Do Not Require Calcium.
Mitochondrial membrane potential can function independent of
changes in intracellular calcium in the range of 0–400 nM (16).
We tested the effect of activation of ICa-L on Ψm in wt and mdx
myocytes in calcium-free and EGTA-containing Hepes-buffered
solution (HBS). Exposure of wt myocytes to BayK(-) increased
Ψm measured as changes in JC-1 signal by 12.1 ± 1.4% compared
with wt myocytes exposed to inactive enatiomer BayK(+) (Fig. 2
A, i and D). The response could be attenuated with application
of ICa-L antagonist nisoldipine. In some experiments, wtmyocytes
were incubated in calcium-free EGTA containing HBS for at
least 3 h and perfused intracellularly with 3 mM EGTA and 5 mM
1,2-bis(o-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA)
to deplete intracellular calcium stores. The wt myocytes exhibited
similar increases in Ψm after activation of ICa-L (Fig. 2 A, ii). To
further confirm whether calcium was involved in the response, wt
myocytes that were incubated in calcium-free EGTA containing
HBS for at least 3 h as described above were also exposed to
caffeine (2 μM) that stimulates release of calcium from ryanodine
receptors in the sarcoplasmic reticulum. There was no significant
alteration in JC-1 signal after the addition of caffeine (Fig. 2 C
and D). Exposure of wtmyocytes to caffeine and BayK(-) resulted
in an increase in JC-1 signal similar to that of BayK(-) alone (Fig.
2 C and D).
However, in mdx myocytes, BayK(-) could not elicit an increase
in JC-1 signal (Fig. 2 B and E). The mitochondria in myocytes from
mdx hearts exhibited functional electron transport because the
ATP synthase blocker oligomycin induced a significant increase in
JC-1 signal (Fig. 2E). These data confirm that the alteration in Ψm
in response to BayK(-) does not depend on changes in intracellular
calcium (9, 17). We propose that the loss of regulation of Ψm by
ICa-L in the mdx myocyte results from disruption of the cytoskele-
ton due to the absence of dystrophin.
To determine whether the response depended on the presence
of dystrophin, we injected mdx mice with 10 mg/kg per wk phos-
phorodiamidate morpholino oligomer (PMO) targeting mouse
dystrophin exon 23 for 24 wk. This treatment induces removal of
exon 23 during processing of the primary transcript and results in
expression of a slightly shorter dystrophin protein (18). Similar
therapy is being administered to Duchenne muscular dystrophy
patients in clinical trials with excellent results demonstrated as
maintaining ambulation (19, 20). Uptake of the oligomers in
mouse cardiac muscle can be detected as evidence of exon skipping
on RT-PCR (Fig. 2 F, i), by the presence of dystrophin on immu-
noblot (Fig. 2 F, ii) and immunohistochemistry staining in cry-
osections (Fig. 2G). We find that BayK(-) can elicit a significant
increase in JC-1 signal in myocytes isolated from hearts ofmdxmice
treated with PMOs, indicating that treatment with oligomers “res-
cued” the JC-1 response (Fig. 2 B and E). These data confirm that
the alteration in Ψm in response to BayK(-) requires dystrophin.
Activation of ICa-L Increases Metabolic Activity in wt but Not mdx
Myocytes. We examined whether activation of ICa-L altered meta-
bolic activity in myocytes isolated from mdx hearts. Consistent with
previous results (9), BayK(-) elicited a significant increase in met-
abolic activity (assessed as formation of formazan from tetrazolium
salt) in myocytes from wtmice (Fig. 3 A and B). The response could
be attenuated with application of nisoldipine or block of calcium
uptake into the mitochondria (Ru360), but not with an inhibitor of
the ryanodine receptor (dantrolene; Fig. 3B). However, in myocytes
from mdx hearts, BayK(-) could not elicit an increase in metabolic
activity (Fig. 3 A and C). Application of oligomycin caused a sig-
nificant decrease in metabolic activity, indicating the cells were
metabolically active (Fig. 3C).
We also examined changes in mitochondrial electron transport
by measuring alterations in flavoprotein oxidation (as autofluo-
rescence) in the myocytes in response to activation of ICa-L. In wt
myocytes, BayK(-) caused a small but significant increase in
flavoprotein oxidation that could be attenuated with application
of nisoldipine (Fig. 3 D and F). However, BayK(-) could not
elicit an increase in flavoprotein oxidation in mdx myocytes de-
spite an increase recorded in response to application of carbonyl
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) (Fig. 3 E
and G). To determine whether the response depended on the
presence of dystrophin, we examined the effect of BayK(-) on
flavoprotein oxidation in myocytes isolated from hearts of PMO-
treated mdx mice. We find that BayK(-) can elicit a significant
increase in flavoprotein oxidation in myocytes isolated from
hearts of PMO-treated mdx mice, indicating that treatment with
oligomers partially rescued the response (Fig. 3 E and G). These
data provide evidence that loss of regulation of metabolic activity
by ICa-L in the mdx myocyte results from disruption of the cyto-
skeleton due to the absence of dystrophin.
ICa-L Associates with the Mitochondrial VDAC via Cytoskeletal Proteins.
We have demonstrated that activation of ICa-L results in an increase
in Ψm in guinea-pig ventricular myocytes, and the response depends
on an intact cytoskeleton because disruption of F-actin filaments
attenuated the increase in Ψm (9). We assessed alterations in Ψm in
myocytes from wt mice treated with either latrunculin A to de-
polymerize F-actin filaments, or a peptide directed toward the AID
of ICa-L (AID-TAT) to immobilize the auxiliary beta subunit of
ICa-L. Myocytes treated with either latrunculin A or AID-TAT
demonstrated attenuation of increased Ψm following exposure to
BayK(-) (Fig. 4 A and E). These data suggest that the response
depends on an intact cytoskeletal architecture.
Voltage-dependent anion channel (VDAC) resides in the
outer mitochondrial membrane and associates with the adenine
nucleotide translocator (ANT) that is located in the inner mi-
tochondrial membrane (21). The VDAC/ANT complex is re-
sponsible for trafficking of ATP/ADP in and out of the mito-
chondria (22). Because Ψm depends on the function of the VDAC/
ANT complex, we investigated whether ICa-L was associated with
the outer mitochondrial membrane protein VDAC. We immuno-
precipitated VDAC protein from hearts of 8-wk-old wt and mdx
mice and immunoblotted the protein against an ICa-L antibody. We
identified a band at ∼220 kDa on immunoblot consistent with ICa-L
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protein (Fig. 4 B, i). Conversely, when we immunoprecipitated ICa-L
protein and probed the protein with anti-VDAC antibody, we
identified a protein at 37 kDa, consistent with VDAC (Fig. 4 B, i).
The immunoprecipitated ICa-L proteins from wt heart and mdx
heart were analyzed by mass spectrometry on a Velos Orbitrap
(Tables S1–S4). A number of similar proteins were identified
in immunoprecipitated protein from wt heart and mdx heart,
including the α1C pore forming and auxiliary beta subunits of ICa-L.
Known regulators of ICa-L function were identified, including
β-tubulin, Ca2+/calmodulin-dependent protein kinase II (CaMKII),
and A-kinase anchor protein (AKAP) (23–25) (Fig. 4 B, ii). Pro-
teins that were identified in wt hearts and not mdx hearts, and
proteins identified in mdx hearts but not wt hearts, are listed in
Table S4. Consistent with our in vitro data (Fig. 4 A and E), F-actin
Fig. 2. Direct activation of ICa-L results in an increase in Ψm in wt but not mdx myocytes under calcium-free conditions. (A) Representative ratiometric JC-1
fluorescence recorded from wt myocytes before and after exposure to 10 μM BayK(+) or 10 μM BayK(-) under calcium-free conditions (0 mM Ca2+) as in-
dicated. Vertical arrow indicates when drug was added. Four micromolar KCN was added to collapse Ψm as indicated. ES, external solution; IS, internal so-
lution. (B) Representative traces of JC-1 fluorescence recorded frommdxmyocytes and myocytes frommdxmice treated with PMO (“mdx rescue”; see text for
detail) before and after exposure to 10 μM BayK(+) or 10 μM BayK(-) under calcium-free conditions (0 mM Ca2+). Vertical arrow indicates when drug was
added. (C) Representative traces of JC-1 fluorescence recorded from wt myocytes before and after exposure to 2 μM caffeine (Caff) or 2 μM Caff and 10 μM
BayK(-) under calcium-free conditions (0 mM Ca2+) as indicated. Vertical arrow indicates when drug was added. (D and E) Mean ± SEM of increases in JC-1
fluorescence for all wtmyocytes (D), and allmdxmyocytes including myocytes frommdxmice treated with PMO (“mdx rescue”) (E), exposed to treatments as
indicated. Nisol: 10 μM nisoldipine; Oligo: 20 μM oligomycin. Oligo alone induced a robust increase in JC-1 signal inmdxmyocytes. (F, i) RT-PCR performed on
cardiac muscle RNA from mdx mice treated with PMO demonstrating exon 23 skipping (Δ23), as indicated by arrow. (F, ii) Immunoblot performed on cardiac
muscle from C57BL/10 control mice, untreatedmdxmice (mdx control), andmdxmice treated with PMO demonstrating presence of dystrophin (mdx treated),
as indicated by arrow (2% and 1% dilution shown). (G) Immunostaining of heart and diaphragm cryosections from a C57BL/10 control mouse, untreatedmdx
mouse (mdx control), and mdx mouse treated with PMO (mouse 12-08-50) demonstrating presence of dystrophin (mdx treated). (Scale bars: 100 μm.)
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was identified as a cytoskeletal partner with ICa-L. In addition,
VDAC and ANT were identified in the immunoprecipitated ICa-L
protein. These data suggest ICa-L associates with the mitochondrial
VDAC via cytoskeletal proteins, one of which is F-actin. The dis-
rupted cytoskeletal architecture due to the absence of dystrophin
leads to altered function between ICa-L and mitochondria.
Preventing Anion Flux Through the VDAC “Restores” the Increase in
Ψm in mdx Myocytes. We directly blocked anion transport from
the outer mitochondrial membrane with application of a peptide
derived against VDAC. The VDAC peptide blocks VDAC at the
mitochondrial outer membrane. In wt myocytes, application of
the VDAC peptide increased JC-1 signal in a similar manner to
BayK(-) (Fig. 4 C, ii and E). A scrambled VDAC peptide had no
effect. When the VDAC peptide was applied to mdx myocytes,
the JC-1 signal increased significantly (Fig. 4 D, ii and F) in
a similar manner to the response recorded after application of
BayK(-) alone in wt myocytes (Fig. 4 C, ii and E). This response
was also observed in myocytes incubated in calcium-free
EGTA containing HBS for at least 3 h and perfused in-
tracellularly with EGTA and BAPTA to deplete intracellular
calcium stores (wt, Fig. 4 C, i; mdx, Fig. 4 D, i). These data
confirm that mitochondria exhibit functional electron transport
in mdx myocytes because a block of VDAC can increase Ψm.
Application of VDAC restored the increase in Ψm inmdxmyocytes.
Taking into account that ICa-L immunoprecipitates with VDAC
Fig. 3. Direct activation of ICa-L results in an increase in metabolic activity and flavoprotein oxidation in wt but notmdxmyocytes. (A) Formation of formazan
measured as change in absorbance in 8-wk-old wt and 8-wk-old mdx myocytes after addition of 10 μM BayK(+) or 10 μM BayK(-). (B and C) Mean ± SEM of
increases in absorbance for wt myocytes (B) and mdx myocytes (C), exposed to treatments as indicated. Dant,10 μM dantrolene; Nisol, 10 μM nisoldipine;
Oligo: 20 μM oligomycin; Ru360, 10 μM Ru360. (D and E) Representative traces of flavoprotein fluorescence recorded fromwtmyocytes (D), andmdxmyocytes
and myocytes from mdx mice treated with PMO (“mdx rescue”) (E), before and after exposure to 10 μM BayK(+) or 10 μM BayK(-). Vertical arrow indicates
when drug was added. 10 μM FCCP was added to increase flavoprotein signal, confirming the signal was mitochondrial in origin. (F and G) Mean ± SEM of
increases in flavoprotein fluorescence for all wt myocytes (F), and allmdx myocytes including myocytes from mdx mice treated with PMO (“mdx rescue”) (G),
exposed to treatments as indicated. FCCP, 10 μM FCCP; Nisol, 10 μM nisoldipine.
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(Fig. 4 B, i and ii), we suggest that activation of ICa-L may increase
Ψm in wt myocytes via transmission of movement of cytoskeletal
proteins to VDAC.
Activation of ICa-L Increases Ψm in wt but Not mdx Myocytes with
Established Cardiomyopathy. We isolated myocytes from 43-wk-
old mdx hearts that had developed cardiomyopathy as assessed
Fig. 4. VDAC coimmunoprecipitates with ICa-L, and direct block of VDAC restores the increase in Ψm inmdxmyocytes. (A) Regulation of Ψm by ICa-L requires an
intact cytoskeleton. Representative ratiometric JC-1 fluorescence is recorded from wt myocytes before and after addition of 10 μM BayK(-) in the presence or
absence of 5 μM Latrunculin A (Latrunc) (i), or 1 μM AID(S)-TAT or 1 μM active AID-TAT peptide (ii), under calcium-free conditions (0 mM Ca2+). Vertical arrow
indicates when drug was added. Four micromolar KCN was added to collapse Ψm as indicated. ES, external solution; IS, internal solution. (B) ICa-L associates
with mitochondrial VDAC via cytoskeletal proteins. (i) Immunoblot of 10 μg of immunoprecipitated VDAC protein from wt (Left) and mdx (Right) heart
probed with anti-ICa-L antibody (Upper) and 10 μg immunoprecipitated ICa-L protein probed with anti-VDAC antibody (Lower). Negative control immunoblots
were performed on 10 μg of immunoprecipitated VDAC protein from wt (Left) and mdx (Right) heart by probing with MS antibody (Upper), and on 10 μg of
immunoprecipitated ICa-L protein from wt (Left) and mdx (Right) heart by probing with α-GOLD antibody (Lower). (ii) Mass spectrometry analysis of
immunoprecipitated ICa-L protein. AKAP, A-kinase anchor protein; ANT, adenine nucleotide translocator; CaMKII, Ca
2+/calmodulin-dependent protein kinase
II; LTCC, L-type Ca2+ channel; MAPK, mitogen-activated protein kinase; PKC, protein kinase C; TK, tyrosine kinase. (C) Application of a peptide that blocks
VDAC mimics the increase in Ψm in wt myocytes. Representative ratiometric JC-1 fluorescence is recorded from wt myocytes before and after exposure to 10
μM BayK(-), 10 μM VDAC peptide (VDAC), or 10 μM VDAC scrambled peptide [VDAC(S)] under calcium-free (0 mM Ca2+) conditions (i), or 2.5 mM calcium (ii).
Vertical arrow indicates when drug was added. Four millimolar KCN was added to collapse Ψm as indicated. ES, external solution; IS, internal solution. (D)
Application of a peptide that blocks VDAC restores the increase in Ψm in mdx myocytes. Representative ratiometric JC-1 fluorescence recorded from mdx
myocytes before and after exposure to 10 μM BayK(-), 10 μM VDAC peptide (VDAC), or 10 μM VDAC scrambled peptide [VDAC(S)] under calcium-free (0 mM
Ca2+) conditions (i) or 2.5 mM calcium (ii). Vertical arrow indicates when drug was added. ES, external solution; IS, internal solution. (E and F) Mean ± SEM of
increases in JC-1 fluorescence for all wt myocytes (E), and all mdx myocytes (F), exposed to treatments as indicated.
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on echocardiography (26) (Table S5) and examined the effect of
activation of ICa-L on Ψm. Similar to results recorded in myocytes
from 8-wk-old mdx mice, exposure of 43-wk-old wt myocytes to
BayK(-) increased Ψm measured as changes in JC-1 signal by 9.74 ±
2.76% compared with wt myocytes exposed to inactive enantiomer
BayK(+) (Fig. 5 A and C). The response could be attenuated with
application of ICa-L antagonist nisoldipine. However, in 43-wk-old
mdx myocytes BayK(-) could not elicit an increase in JC-1 signal
(Fig. 5 B and D). Myocytes from mdx hearts exhibited functional
electron transport because the ATP synthase blocker oligomycin
induced a significant increase in JC-1 signal (Fig. 5D). To further
confirm that the signal was measuring changes in Ψm, we induced
a collapse of Ψm with application of KCN.
We also examined the effect of activation of ICa-L on metabolic
activity in myocytes isolated from 43-wk-old mdx hearts. Similar to
results recorded in myocytes from 8-wk-old wt mice, BayK(-) eli-
cited a significant increase in metabolic activity in myocytes from
wt mice (Fig. 5 E and F). The response could be attenuated with
application of nisoldipine or block of calcium uptake into the
mitochondria (Ru360) but not with an inhibitor of the ryanodine
receptor (dantrolene; Fig. 5F). However, in myocytes from 43-wk-
old mdx hearts BayK(-) could not elicit a further increase in
Fig. 5. Direct activation of ICa-L results in an increase in Ψm and metabolic activity in wt but not mdx myocytes isolated from 43-wk-old mice. (A and B) Rep-
resentative ratiometric JC-1 fluorescence recorded from wt myocytes (A), and mdx myocytes (B), before and after exposure to 10 μM BayK(+) or 10 μM BayK(-).
Vertical arrow indicates when drug was added. Four micromolar KCN was added to collapse Ψm as indicated. (C and D) Mean ± SEM of increases in JC-1 fluo-
rescence for all wt (C) andmdx (D) myocytes exposed to treatments as indicated. Nisol, 10 μM nisoldipine; Oligo, 20 μM oligomycin. Oligo alone induced a robust
increase in JC-1 signal inmdxmyocytes. (E) Formation of formazan measured as change in absorbance inwt andmdxmyocytes after addition of 10 μMBayK(+) or
10 μM BayK(-). (F and G) Mean ± SEM of increases in absorbance for wt myocytes (F) and mdx myocytes (G), exposed to treatments as indicated. Dant, 10 μM
dantrolene; Nisol, 10 μM nisoldipine; Oligo, 20 μM oligomycin; Ru360, 10 μM Ru360. (H) Respiration and complex activity in mitochondria isolated from 43-wk-old
wt hearts and 43-wk-old mdx hearts (see Materials and Methods for details).
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metabolic activity (Fig. 5 E and G). Application of oligomycin
caused a significant decrease in metabolic activity, indicating the
cells were metabolically active (Fig. 5G).
To determine whether the alterations in metabolic activity in the
mdx myocyte were specific to the mitochondria, we isolated mito-
chondria from hearts of 43-wk-old mdx mice. Respiratory complex
activity and oxygen consumption were similar to that recorded in
mitochondria isolated from 43-wk-old wt hearts (Fig. 5H). These
data confirm that alterations in mitochondrial function occur early
and persist up to the development of cardiomyopathy.
Taken together, our data suggest that the alterations in mito-
chondrial function depend on activation and inactivation of ICa-L in
the intact cell and occur because of altered transmission of move-
ment from ICa-L through cytoskeletal proteins to the mitochondria.
Discussion
Duchenne muscular dystrophy is a fatal X-linked disease char-
acterized by the absence of dystrophin that is associated with
cytoskeletal protein disarray, contractile dysfunction, and re-
duced energy production (1, 2). However, the mechanisms for
altered energy metabolism are not fully understood. We have
shown that activation of ICa-L alters mitochondrial function via
the movement of cytoskeletal proteins (9, 12). The response de-
pends on an intact cytoskeleton (9). In this study, we examined
whether the lack of dystrophin (and associated cytoskeletal dis-
array; refs. 27–29) in ventricular myocytes isolated from mdx
mice results in impaired communication between ICa-L and the
mitochondria.
First, we characterized the kinetics of ICa-L current inactiva-
tion. We and others have demonstrated that disruption of the
cytoskeleton alters ICa-L kinetics (11–13). We find that myocytes
from mdx hearts exhibit a delayed inactivation of ICa-L (Fig. 1A).
This finding is consistent with an alteration in movement of the
auxiliary beta subunit of ICa-L because immobilization of the beta
subunit with a peptide derived against the alpha-interacting do-
main also slows inactivation of the current (Fig. 1A, Inset). This
finding is also consistent with previous studies that have dem-
onstrated that dissociation of microtubules or depolymerization
of actin alters the inactivation rate of ICa-L (5, 23, 29).
Disruption of the cytoskeleton is associated with alterations in
mitochondrial function. Unlike wt myocytes, Ψm did not increase
after activation of ICa-L in mdx myocytes (Figs. 1 and 2). In ad-
dition, metabolic activity and oxidation of flavoprotein did not
increase after activation of ICa-L in mdx myocytes (Fig. 3). Con-
sistent with previous studies (2), these data suggest that metabolic
activity in the mdx myocyte is significantly different from the wt
myocyte. Similar responses were observed inmdxmyocytes isolated
from hearts of 43-wk-old mice that had developed cardiomyopathy
(Fig. 5). However, respiration was normal in mitochondria isolated
from 43-wk-old mice, indicating that the responses depend on an
association between ICa-L and the cytoskeleton in the intact cell
(Fig. 5). Consistent with this finding, previous studies in desmin-
null mice have demonstrated abnormal mitochondrial respiration
in vivo, whereas the rates of maximal respiration in isolated mi-
tochondria from desmin-null mice were similar to mitochondria
isolated from wt mice (30). In another study, although mitochon-
drial distribution was normal in the hearts of 10- to 11-mo-old mdx
mice, a lack of dystrophin was associated with impaired coupling of
mitochondrial-creatine kinase to oxidative phosphorylation and
altered ADP uptake by the mitochondria only in intact skinned
fibers (31). Our data demonstrate that cytoskeletal disruption due
to the absence of dystrophin results in the loss of regulation of
mitochondrial function by ICa-L in intact mdx myocytes. Because
ICa-L initiates contraction in the beating heart, we propose that
altered communication between ICa-L and the mitochondria con-
tributes to poor metabolic activity in the mdx contracting heart
demonstrated as a decrease in fractional shortening on echocar-
diography (Table S5). Although cytosolic and mitochondrial cal-
cium are increased in the mdx myocyte (12, 32, 33), we propose
that altered regulation of VDAC by ICa-L may contribute to the
poor metabolic activity.
In this study, we demonstrate that treatment of mice with a
PMO targeting dystrophin restores regulation of mitochondrial
function by ICa-L in the mdx myocyte (Figs. 2 and 3). These data
confirm that the absence of dystrophin is responsible for the lack
of response of the mitochondria to activation of ICa-L. The data
also demonstrate that treatment with PMOs offers a promising
therapy for Duchenne muscular dystrophy cardiomyopathy.
VDAC resides in the outer mitochondrial membrane and
associates with ANT that is located in the inner mitochondrial
membrane (21). The VDAC/ANT complex is responsible for
trafficking of ATP/ADP in and out of the mitochondria (22).
VDAC and the cytoskeletal protein β-tubulin are closely asso-
ciated and may play a role in regulation of mitochondrial res-
piration (34, 35). We examined whether ICa-L is associated with
VDAC by immunoprecipitating the ICa-L protein. Immunoblot
and pull-down analysis confirmed that VDAC associates with
ICa-L (Fig. 4B). In addition, we provide functional evidence that
the ICa-L communicates with VDAC. We demonstrate that pre-
venting the opening of VDAC with application of a peptide di-
rected toward VDAC restores the increase in JC-1 in mdx hearts
(Fig. 4 C and D). These data to our knowledge are the first to
demonstrate that ICa-L communicates with the mitochondria
through an association with outer membrane mitochondrial protein
VDAC via cytoskeletal proteins. We propose that communication
between ICa-L and the mitochondria occurs via transmission of
movement from ICa-L (during activation and inactivation of ICa-L) to
mitochondrial VDAC through F-actin (Fig. 6A). We find that this
structural and functional communication between ICa-L and the
Fig. 6. Schematic representation of communication of ICa-L with the outer
membranemitochondrial protein VDAC via cytoskeletal proteins (A), and altered
cytoskeletal network in hearts lacking dystrophin (B) (see text for details).
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mitochondria is altered in hearts lacking dystrophin (Fig. 6B). Ab-
normalities occur only in the intact cell.
The VDAC/ANT complex is responsible for shuttling ATP out
of the mitochondria (36). This shuttling is critical to meeting
energy demands of the heart. Here, we find that the absence of
dystrophin and disrupted cytoskeletal architecture in the mdx
ventricular myocyte leads to impaired communication between
ICa-L and mitochondrial VDAC. This alteration results in reduced
metabolic activity in the mdx ventricular myocyte. These findings
provide newmechanistic and functional insight into cardiomyopathy
associated with Duchenne muscular dystrophy.
Materials and Methods
Isolation of Ventricular Myocytes. Myocytes were isolated from 8-wk-old and
43-wk-old male C57BL/10ScSn-Dmdmdx/Arc (mdx) and C57BL/10ScSnArc wt
mice. A total number of 110 wt and 67 mdx mice were used. Four mdx mice
were treated with PMO at 10 mg/kg per week by i.p. injection for 24 wk
from 7 d of age. Cells were isolated as described (37). For full details, see SI
Materials and Methods.
Data Acquisition for Patch-Clamp Studies. The whole-cell configuration of the
patch-clamp technique was used to measure changes in ICa-L currents in intact
ventricular myocytes (37, 38). Microelectrodes with tip diameters of 3–5 μm
and resistances of 0.5–1.5 MΩ contained the following: 115 mM CsCl, 10 mM
Hepes, 10 mM EGTA, 20 mM tetraethylammonium chloride, 5 mM MgATP,
0.1 mM Tris-GTP, 10 mM phosphocreatine, and 1 mM CaCl2 (pH adjusted to
7.05 at 37 °C with CsOH). Currents were measured in extracellular modified
Tyrode’s solution containing the following: 140 mM NaCl, 5.4 mM CsCl, 2.5
mM CaCl2, 0.5 mM MgCl2, 5.5 mM Hepes, and 11 mM glucose (pH adjusted
to 7.4 with NaOH). Barium currents were measured by using internal solu-
tion containing the following: 125 mM CsCl, 10 mM Hepes, 0.1 mM EGTA,
20 mM tetraethylammonium chloride, 5 mM MgATP, 0.1 mM Tris-GTP, and
10 mM phosphocreatine (pH adjusted to 7.05 at 37 °C with CsOH), and ex-
ternal solution containing the following: 152.5 mM tetraethylammonium
chloride, 10 mM Hepes, and 10 mM BaCl2 [pH adjusted to 7.4 with Ba(OH)2].
Macroscopic currents were recorded by using an Axopatch 200B voltage-
clamp amplifier (Molecular Devices) and an IBM compatible computer with
a Digidata 1322A interface and pClamp9 software (Molecular Devices). A
Ag/AgCl electrode was used to ground the bath. Once the whole-cell con-
figuration was achieved, the holding potential was set at –80 mV. Na+
channels and T-type Ca2+ channels were inactivated by applying a 50-ms
prepulse to –30 mV immediately before each test pulse. The time course of
changes in Ca2+ conductance were monitored by applying a 100-ms test
pulse to 10 mV once every 10 s. All experiments were performed at 37 °C.
Fluorescent Studies. The fluorescent indicator 5,5′,6,6′-tetrachloro-1,1′,3,3′-
tetraethylbenzimidazolylcarbocyanine iodide was used to measure Ψm at
37 °C as described (38). For full details, see SI Materials and Methods. To
confirm that the JC-1 signal was indicative of Ψm, 4 mM KCN was added at
the end of each experiment to collapse Ψm. For calcium-free experiments,
cells were exposed to calcium-free HBS (containing 3 mM EGTA) for at least
3 h, before measuring changes in Ψm. In some experiments, cells were exposed
to calcium-free HBS for at least 3 h and then patch-clamped with pipette
solution containing the following: 115 mM CsCl, 10 mM Hepes, 5 mM
BAPTA, 3 mM EGTA, 20 mM tetraethylammonium chloride, 5 mM MgATP,
0.1 mM Tris-GTP, 10 mM phosphocreatine (pH adjusted to 7.05 at 37 °C with
CsOH), and 200 nM JC-1. Changes in Ψm were then assessed.
Flavoprotein autofluorescence was used to measure flavoprotein oxida-
tion in intact mouse cardiac myocytes based on described methods (39). For
full details, see SI Materials and Methods. Ten micromolar FCCP was added
at the end of each experiment to achieve a maximum fluorescence value
indicative of maximum flavoprotein oxidation.
RNA Preparation and RT-PCR Analysis, Immunostaining, and Immunoblot. Total
RNAwas extracted from the hearts, and RT-PCRwas performed for analysis of
exons 22–24 (Table S6). Dystrophin protein was stained on diaphragm and
heart cryosections by using NCL-Dys2 and Zenon Alexafluor 488. Sections
from untreated mdx and wt mice are included for comparison. All images
were captured and processed by using identical parameters (18, 40). Dys-
trophin protein was assessed on immunoblot as described (40, 41). For full
details, see SI Materials and Methods.
Yellow Tetrazolium Salt Assay. The rate of cleavage of yellow tetrazolium salt
to purple formazan crystals by themitochondrial electron transport chainwas
measured spectrophotometrically at 570 nm with a reference wavelength
of 620 nm at 37 °C as described (9). Each n represents number of animals
used in each treatment group for the assay. For full details, see SI Materials
and Methods.
Immunoprecipitation of ICa-L and VDAC Protein and Immunoblot. Membrane
fractions were prepared from crude heart homogenates as described (42).
Immunoprecipitation and immunoblot were performed as described (25,
42), using either anti-ICa-L antibody (ACC-004; Alomone Labs) or anti-porin
antibody (MSA03; MitoSciences). Immunoprecipitation was performed by
using PureProteome Protein G Magnetic Beads (Millipore). Rabbit polyclonal
antibody raised in house against a gold N-heterocyclic carbene compound
(α-GOLD) or serum from pooled BALB/c and C57BL/6 mice (MS) were used as
negative controls. For full details, see SI Materials and Methods.
Mass Spectrometry Analysis of Immunoprecipitated ICa-L Protein. Digest pep-
tides were separated by nano-LC using an Ultimate 3000 HPLC and auto-
sampler system (Dionex) at The Bioanalytical Mass Spectrometry Facility,
University of New South Wales, Sydney. Samples were analyzed by using an
Orbitrap Velos (Thermo Electron) mass spectrometer. For full details, see SI
Materials and Methods.
Mitochondrial Respiration Studies.Mitochondrial respiration was measured in
mitochondria isolated from three pooled wt mouse hearts and from three
pooled mdx mouse hearts by using a OROBOROS high resolution respi-
rometer thermostatically maintained at 37 °C as described (43). For full
details, see SI Materials and Methods.
Statistical Analysis. Results are reported as mean ± SEM. Statistical compar-
isons of responses between unpaired data were made by using the Student
t test or between groups of cells by using one-way ANOVA and the Tukey’s
post hoc test (GraphPad Prism version 5.04).
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